Career history of Lisa A. Hayes
Former positions of Lisa A. Hayes
Companies | Position | Start | End |
---|---|---|---|
CYTEIR THERAPEUTICS, INC. | Investor Relations Contact | 31/01/2021 | 31/01/2023 |
Public Communications Contact | 31/01/2021 | 31/01/2023 | |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
PROQR THERAPEUTICS N.V. | Investor Relations Contact | 12/12/2018 | - |
Public Communications Contact | 12/12/2018 | - | |
CELGENE | Public Communications Contact | - | - |
Training of Lisa A. Hayes
St. Joseph's University | Masters Business Admin |
New York University | Graduate Degree |
Seton Hall University | Undergraduate Degree |
Statistics
International
United States | 7 |
Netherlands | 2 |
Operational
Public Communications Contact | 4 |
Investor Relations Contact | 3 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
Private companies | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
- Stock Market
- Insiders
- Lisa A. Hayes
- Experience